Nitazenes: Dangers, Testing, and Naloxone Facts

Not medical advice. Harm reduction information for people who have already decided to use. In an emergency, call your local emergency number. Some links are affiliate links; we may earn a commission at no cost to you. As an Amazon Associate we earn from qualifying purchases.

Contents

What nitazenes are, and why they came back
What the death data actually shows
How strong they really are
Naloxone: what the evidence supports
Testing: what each strip can and cannot see
How to protect yourself
The bottom line
Sources

Nitazenes are a family of lab-made opioids that are showing up in counterfeit pills, heroin, powders and vape liquids, and fentanyl test strips do not cover them. Confirmed US deaths involving nitazenes rose from 27 in 2020 to 409 in 2024 in CDC’s overdose reporting system, with more than 1,100 confirmed since 2019. In England and Wales, 195 deaths involved a nitazene in 2024, nearly four times the 2023 figure. Naloxone does reverse them, usually at ordinary doses. The three things that protect you: separate nitazene test strips, two doses of naloxone within reach, and never using alone.

Quick answers

What are nitazenes? Opioids built on a 2-benzylbenzimidazole structure, first made in the 1950s and never sold as medicines because the overdose risk was too high. Names to know: isotonitazene, metonitazene, protonitazene, etonitazene and their “pyne” relatives.

Do fentanyl test strips detect nitazenes? No. They are a different molecule shape, and the same companies sell separate nitazene strips. There is no published head-to-head test of fentanyl strips against nitazenes, but a lab study of two strip brands found they missed all 31 non-fentanyl opioids tested.

Does Narcan work on nitazenes? Yes. A 2025 review of confirmed cases found a median dose of 1.2 mg of injected naloxone reversed poisoning. Some people needed continuous infusions, so repeat dosing and monitoring matter.

Are they stronger than fentanyl? Some are, in lab tests. In real cases, blood levels look similar to fentanyl’s, so “roughly fentanyl-grade danger, with a wide range” is the honest summary.

Where do they show up? In counterfeit oxycodone and benzo pills, in heroin, in powders, and in vape liquids. Most people who die did not know they took one.

What nitazenes are, and why they came back

Nitazenes were developed as painkillers in the 1950s and abandoned because they suppressed breathing at doses too close to the doses that relieved pain (PMID 40422647). They returned to street markets in 2019 with isotonitazene, and the family keeps growing: at least 26 variants have been reported in the US since then. When one gets banned, a slightly modified version appears.

They spread because they are cheap to make and easy to ship. Most reach buyers through dark web markets, chemical supplier sites and social media, in small mail packages.

What the death data actually shows

United States. Confirmed nitazene deaths in CDC’s State Unintentional Drug Overdose Reporting System went from 27 in 2020 to 409 in 2024, with more than 1,100 confirmed since 2019 and researchers estimating the true total nearer 2,000. Ohio accounts for over a third of all positive nitazene lab reports, with Florida second. Seized-drug data tell a similar story: nitazene reports to the DEA’s national forensic lab system rose from 43 in 2019 to 1,905 in 2024, though the count levelled off after 2021. The mix also shifted from isotonitazene toward metonitazene and protonitazene, and 98% of nitazene-positive biological samples contained at least one other drug, most often fentanyl (PMID 41785913).

United Kingdom. The Office for National Statistics recorded 195 deaths involving nitazenes in England and Wales in 2024, up from 52 in 2023. A King’s College London analysis found coroners judged nitazenes to be a cause in 90 percent of 285 reported deaths, and that the real count is probably higher: nitazenes break down in post-mortem blood samples, so some deaths get missed entirely (PMID 41655595).

Norway. All 36 nitazene deaths from 2021 to 2024 were reviewed. The median age was 29, 94 percent were male, over 90 percent had other drugs on board, and half had a designer benzodiazepine (PMID 41477999). The authors’ conclusion was that inexperienced users need better warning, because these are not deaths concentrated among long-term opioid users.

How strong they really are

This is where most coverage goes wrong, in both directions.

In the lab, some are far stronger than fentanyl. A National Institute on Drug Abuse study tested five nitazenes in mice and found the strength depends on one part of the molecule, the alkoxy chain. Etonitazene was the most potent, activating the mu-opioid receptor at 30 picomolar and producing opioid effects at 3 to 12 micrograms per kilogram, well below fentanyl. Compounds with ethoxy, isopropoxy and propoxy chains beat fentanyl; methoxy and butoxy versions were weaker (PMID 37658878). That was injected dosing in mice, so it shows the pattern, not a human dose.

In people, the picture is more modest. A 2025 systematic review of 35 studies found that real-world potency runs consistently lower than the lab numbers, and post-mortem nitazene levels resemble those in fentanyl deaths (PMID 40422647). A review of 93 nitazene fatalities found median blood concentrations of 1.7 ng/mL for isotonitazene and 5.4 ng/mL for metonitazene, again consistent with fentanyl-like potency (PMID 35149665).

The practical takeaway is not a potency ranking. It is that the label tells you nothing about which variant you have or how much is in there, and the range across variants is enormous.

Naloxone: what the evidence supports

It works. In the 2025 review of confirmed human cases, the median reversal dose was 1.2 mg of injected naloxone, and 0.8 mg in ambulance settings, close to ordinary opioid dosing (PMID 40422647).
Repeat dosing is common. In an Australian cohort of 27 lab-confirmed cases, the median effective dose was 400 micrograms, but 45 percent of treated patients needed repeat doses (PMID 40810707). In the review above, 6 of 30 patients needed a continuous infusion because effects outlasted the naloxone.
The reason is chemical. Some nitazenes, like etonitazene and isotonitazene, come off the receptor slowly, which makes naloxone’s job harder and can require more of it (PMID 39437833). That is a laboratory finding about receptors, not a reason to skip a first dose.
A 2026 review found no support for routinely jumping to very high doses (PMID 42392847).

So: give a standard dose, give another if breathing has not returned in 2 to 3 minutes, and call 911 even if they wake up, because re-sedation is the documented pattern.

Testing: what each strip can and cannot see

Fentanyl strips do not cover nitazenes. Fentanyl strips are built around fentanyl’s shape, and nitazenes are a different scaffold. No published study has directly tested fentanyl strips against nitazene analogs, so treat this as strong inference rather than proof. The supporting evidence: a lab assessment of two major brands found neither detected any of 31 non-fentanyl opioids tested (PMID 38057832), and the manufacturers sell nitazene strips as a separate product. Keep using fentanyl strips anyway, because fentanyl is still the more common contaminant.

Nitazene strips help, with real gaps. Two independent evaluations:

Finding	Ghent University, 2024	University of Dundee, 2025
Coverage	24 of 33 analogs detected	28 of 36 analogs detected (78%)
Detection limit	2,000 to 3,000 ng/mL for isotonitazene, varying by lot	250 ng/mL to 100 µg/mL
Misses	”Desnitazenes” cross-react poorly	8 compounds gave false negatives
False positives	Not observed in 6 real samples	Caffeine above 300 µg/mL triggered them in seized heroin

Sources: PMID 39198843 and PMID 40783738.

Read that as a screen, not a clearance. A positive is meaningful. A negative means “none of the variants this strip covers, above its threshold.” Caffeine is a common cut, so a positive on suspected heroin is worth a second test. DanceSafe and other harm reduction suppliers sell nitazene strips alongside fentanyl and xylazine strips, and only lab mass spectrometry identifies the specific compound; our drug checking guide lists services still operating.

How to protect yourself

Treat every non-pharmacy pill as a possible opioid. A Norwegian case documented a fatal overdose from tablets that looked exactly like oxycodone but contained etonitazepyne (PMID 40694369).
Carry two doses of naloxone. Over the counter at US pharmacies, and free by mail from NEXT Distro.
Never use alone. Never Use Alone: 1-800-484-3731.
Test with the right strip, and know its limits. Fentanyl strips plus nitazene strips answer two different questions. Reagent kits, covered in our test kit guide, identify the drug itself.
Do not stack depressants. Half the Norwegian deaths involved designer benzos, which naloxone does not reverse. Check combinations in our interaction checker.
Start with a fraction and wait. Potency varies hugely between and within batches.
Watch out for vapes and liquids. Vaping was the most common route in the Australian cohort, and a vape gives you no way to judge a dose.

The bottom line

Nitazenes are a moving family of potent opioids that mostly kill people who did not know they were taking an opioid. Deaths have risen sharply in the US, UK and Norway, and ordinary fentanyl strips will not see them. Use nitazene strips as a screen rather than a guarantee, keep two doses of naloxone nearby, and never use alone. For a related opioid with the same blind spot, see our cychlorphine guide, and for testing stimulants see the cocaine and MDMA guides.

Sources